Donor myocardial HIF-1alpha is an independent predictor of cardiac allograft dysfunction: a 7-year prospective,

S Aharinejad1, R Schäfer, K Krenn

  • 1Department of Cardiothoracic Surgery, Medical University of Vienna, Vienna, Austria. seyedhossein.aharinejad@meduniwien.ac.at

Insights

Hypoxia-inducible factor-1 alpha (HIF-1alpha) shows potential as a predictive marker for primary graft dysfunction (PGD) in heart transplantation. Measuring HIF-1alpha levels in donor hearts may help identify PGD risk.

Area of Science:

  • Cardiovascular Biology
  • Transplantation Immunology
  • Molecular Medicine

Background:

  • Primary graft dysfunction (PGD) is a significant complication following heart transplantation.
  • The molecular mechanisms underlying the cardiac response to transplantation-induced stress and their link to PGD are not fully understood.

Purpose of the Study:

  • To investigate the cardiac molecular response to transplantation-induced stress.
  • To identify potential biomarkers for predicting primary graft dysfunction (PGD).

Main Methods:

  • cDNA array analysis identified key mediators including HIF-1, EGR-1, NAB-2, VEGF-A, and uPA.
  • Real-time RT-PCR was used to quantify mRNA expression in left ventricular biopsies from 200 donors.
  • Measurements were taken before aortic cross-clamping and at various reperfusion time points (10, 30, 60 min).

Main Results:

  • Hypoxia-inducible factor-1 alpha (HIF-1alpha) expression at two time points was significantly associated with PGD.
  • HIF-1alpha levels at aortic cross-clamping (78% sensitivity, 83% specificity) and 10-min reperfusion (85% sensitivity, 83% specificity) effectively identified PGD.
  • Other factors were tested, but HIF-1alpha showed the strongest predictive potential.

Conclusions:

  • HIF-1alpha is a promising predictive marker for PGD in heart transplantation.
  • Prospective evaluation is necessary to confirm the predictive value of HIF-1alpha for PGD.

Related Concept Videos